2m 2m 2m 2m 2m 2m 2m
PROTARA THERAPEU (TARA)
NASDAQ
$4.01+$0.005 (+0.12%)
Price as of Jun 23, 2026 4:10 PM EDT- $231.0MMarket Cap
- 30.72%1-Year Change
- BiotechnologyIndustry
PROTARA THERAPEU (TARA)
$4.01+$0.005 (+0.12%)
TARA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.00 | ||
Change | -$0.11 (-2.68%) | ||
Open | $4.06 | ||
High | $4.23 | ||
Low | $4.00 | ||
Previous Close | $4.11 | ||
Volume | 445,406 | ||
30-Day Average Volume | 674,334 | ||
1-Week Change | 4.99% | ||
1-Month Change | -18.70% | ||
1-Year Change | 30.72% | ||
3-Year Change | 58.73% | ||
5-Year Change | -60.63% | ||
Fundamentals | |||
Shares Outstanding | 56.2M | ||
Total Assets | $191.9M | ||
Market Cap | $231.0M | ||
Enterprise Value | $216.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$21.3M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.7M | ||
Net Working Capital | $131.1M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue